Eurax

Eurax is a topical antipruritic and scabicidal medication, formulated with the active ingredient crotamiton, designed to provide rapid and sustained relief from severe itching associated with various dermatological conditions and to eradicate Sarcoptes scabiei mite infestations. As a cornerstone in dermatological therapy, its dual-action mechanism targets both the symptomatic discomfort and the underlying parasitic cause, offering a clinically proven solution for patients suffering from debilitating pruritus. Its efficacy is supported by decades of use in medical practice, making it a trusted choice for healthcare professionals seeking a reliable intervention for pruritic and parasitic skin disorders.

Features

• Contains 10% w/w crotamiton as the active pharmaceutical ingredient.
• Available in a 100g tube or 500g bottle of cream or lotion formulation.
• Emollient-based vehicle that aids in skin hydration while delivering medication.
• Possesses both antipruritic and scabicidal pharmacological properties.
• Designed for topical application only; not for ophthalmic, oral, or intravaginal use.
• Typically requires application to the entire body from the chin down for scabies treatment.
• Stable at room temperature; does not require refrigeration.

Benefits

• Provides rapid relief from intense, localized, or generalized pruritus within hours of application.
• Effectively eliminates scabies mites and their eggs, resolving infestations and preventing transmission.
• Reduces the urge to scratch, thereby minimizing secondary skin damage, lichenification, and potential bacterial infections.
• Soothes irritated skin through its emollient base, improving skin barrier function and comfort.
• Offers a non-corticosteroid alternative for pruritus management, avoiding potential steroid-related side effects.
• Simple, patient-administered treatment regimen supports adherence and successful therapeutic outcomes.

Common use

Eurax is primarily indicated for the treatment of scabies (caused by the Sarcoptes scabiei mite) and for the symptomatic relief of pruritus associated with various dermatoses, including allergic conditions, eczematous dermatitis, and pruritus of unknown origin. It is also utilized off-label for pruritus in elderly patients and in cases where other antipruritic agents are contraindicated or poorly tolerated. Clinical use is common in both outpatient dermatology and general practice settings, particularly for patients presenting with nocturnal itching that disrupts sleep.

Dosage and direction

For Scabies Treatment:

1. Take a bath or shower and dry thoroughly.
2. Apply a thin layer of Eurax cream or lotion to the entire body from the chin down, paying particular attention to areas between fingers and toes, wrists, axillae, buttocks, and genital areas.
3. Avoid application to the face, eyes, mouth, and other mucous membranes.
4. Repeat application 24 hours after the initial application.
5. Take a cleansing bath 48 hours after the second application.
6. Change into clean clothing and bed linens after each application.

For Pruritus Relief:

1. Apply a thin layer to affected areas 2-3 times daily, or as directed by a physician.
2. Gently massage into the skin until absorbed.

A second course of treatment may be necessary if scabies symptoms persist after one week. Consult a healthcare provider for reassessment.

Precautions

• For external use only. If contact with eyes occurs, rinse immediately with copious amounts of water.
• Do not apply to acutely inflamed, raw, or exudative skin surfaces due to risk of increased absorption and irritation.
• Discontinue use if hypersensitivity or severe irritation develops.
• Use with caution in patients with known sensitivity to any component of the formulation.
• Not recommended for use in infants under 3 years of age unless specifically advised by a pediatrician.
• Keep out of reach of children and pets.

Contraindications

• Hypersensitivity to crotamiton or any excipient in the formulation.
• Application to patients with a history of allergic contact dermatitis to topical scabicides or antipruritics.
• Should not be used on patients with widespread pustular or bullous lesions.
• Avoid use in premature infants or neonates due to immature skin barrier and potential for systemic absorption.

Possible side effect

Most adverse reactions are mild and localized. They may include:

• Transient burning, stinging, or itching at the application site.
• Erythema, edema, or skin rash.
• Allergic contact dermatitis in susceptible individuals.
• Rare cases of generalized skin reactions or hypersensitivity.

If severe irritation or systemic symptoms (e.g., dizziness, nausea) occur, discontinue use and consult a healthcare provider.

Drug interaction

No significant pharmacokinetic drug interactions have been reported with topical crotamiton. However:

• Concurrent use with other topical medications (e.g., corticosteroids, retinoids) may increase the risk of skin irritation or alter absorption. Apply Eurax first and allow to absorb before applying other products, or as directed by a physician.
• Avoid concomitant use with other scabicidal agents unless specifically prescribed.

Missed dose

If a dose is missed during scabies treatment, apply as soon as remembered. If it is nearly time for the next application, continue with the regular schedule. Do not double the dose. For pruritus relief, apply when needed, adhering to the maximum frequency of 2-3 times daily.

Overdose

Topical overdose is unlikely but may lead to increased skin irritation, redness, or discomfort. In case of accidental ingestion, seek medical attention immediately. Symptoms of ingestion may include nausea, vomiting, abdominal pain, or CNS effects. Treatment is supportive.

Storage

• Store at room temperature (15–30°C or 59–86°F).
• Keep the tube or bottle tightly closed.
• Protect from light and excessive heat.
• Do not freeze.
• Discard any unused product 6 months after opening or by the expiration date, whichever comes first.

Disclaimer

This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before using any medication, especially if pregnant, breastfeeding, or managing underlying health conditions. Use only as directed.

Reviews

Eurax is highly regarded in clinical practice for its efficacy in managing stubborn pruritus and eradicating scabies infestations. Dermatologists frequently note its rapid onset of action and favorable safety profile compared to some neurotoxic scabicides. Patient feedback often highlights significant improvement in sleep quality and reduction in itching within days. Some users report mild initial stinging, but overall satisfaction remains high due to the product’s effectiveness and ease of use.